Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.75USD
4:48pm GMT
Change (% chg)

$-0.25 (-5.00%)
Prev Close
$5.00
Open
$5.04
Day's High
$5.15
Day's Low
$4.75
Volume
29,193
Avg. Vol
17,007
52-wk High
$5.85
52-wk Low
$2.10

Chart for

About

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for... (more)

Overall

Beta: --
Market Cap(Mil.): $56.33
Shares Outstanding(Mil.): 10.04
Dividend: --
Yield (%): --

Financials

  ATXI.OQ Industry Sector
P/E (TTM): -- 30.86 33.64
EPS (TTM): -0.53 -- --
ROI: -- 14.72 14.22
ROE: -- 16.27 15.99

Special Report: Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

SPECIAL REPORT-Biotech incubator taps investors through in-house brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman

02 Aug 2018

Earnings vs. Estimates